| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-05 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.27 | 2e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0002 |